Literature DB >> 26886286

Association between p21 Ser31Arg polymorphism and the development of cervical lesion in women infected with high risk HPV.

Géssica Lima1, Erinaldo Santos2, Hildson Angelo3,4, Micheline Oliveira5, Sandra Heráclio6, Fernanda Leite7, Celso de Melo8, Sergio Crovella3,9, Maria Maia2,7, Paulo Souza10,11,12.   

Abstract

Infection by high-risk human papillomavirus (HR-HPV) and single nucleotide polymorphism (SNP) in genes involved in cell cycle control, as p21 and p27, are important factors in the development of different types of human cancers. This study aims at investigating whether both the p21 Ser31Arg and p27 V109G polymorphisms are associated with susceptibility to the development of cervical lesions in women HR-HPV positive. We analyzed 132 women HPV positive and with cervical lesions or CC and 154 healthy control (HPV negative and without cervical lesions). p21 Ser31Arg and p27 V109G polymorphisms were analyzed using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method and sequencing. The p21 31Arg allele was associated with susceptibility for the development of cervical lesions (P* = 0.0009), while p27 V109G polymorphism showed no significant differences for this association (P* = 0.89). However, the combined effect of the polymorphisms showed that the presence of the CC genotype (SNP p21 Ser31Arg) conferred protection for the development of cervical lesions (OR = 0.39). p21 Ser31Arg and p27 V109G polymorphisms were not associated with the grade of cervical lesions (CINI, CINII, and CINIII) or CC (P* > 0.05). The HR-HPV more frequent in this study were of 16 (57.6 %) and 18 (37.1 %) types; however, no association was observed when both polymorphisms and risk factors analyzed were compared (P* > 0.05). Our findings suggest a possible association between p21 Ser31tabArg polymorphism and susceptibility to the development of cervical lesions in women from Pernambuco. Brazil.

Entities:  

Keywords:  Cell cycle; Cervical cancer; HPV; SNPs

Mesh:

Substances:

Year:  2016        PMID: 26886286     DOI: 10.1007/s13277-016-4979-0

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  37 in total

1.  Comprehensive assessment of P21 polymorphisms and lung cancer risk.

Authors:  Yi Young Choi; Hyo-Kyung Kang; Jin Eun Choi; Jin Sung Jang; Eun Jin Kim; Sung Ick Cha; Won Kee Lee; Sin Kam; Chang Ho Kim; Sung Beom Han; Tae Hoon Jung; Jae Yong Park
Journal:  J Hum Genet       Date:  2007-11-28       Impact factor: 3.172

2.  CDKN1B V109G polymorphism a new prognostic factor in sporadic medullary thyroid carcinoma.

Authors:  Daniela Pasquali; Luisa Circelli; Antongiulio Faggiano; Massimo Pancione; Andrea Renzullo; Rossella Elisei; Cristina Romei; Giacomo Accardo; Viviana Raffaella Coppola; Maurizio De Palma; Piero Ferolla; Franco Grimaldi; Annamaria Colao; Vittorio Colantuoni
Journal:  Eur J Endocrinol       Date:  2010-12-21       Impact factor: 6.664

3.  Use of multiple PCR primer sets for optimal detection of human papillomavirus.

Authors:  F Karlsen; M Kalantari; A Jenkins; E Pettersen; G Kristensen; R Holm; B Johansson; B Hagmar
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

Review 4.  Small molecule regulators of Rb-E2F pathway as modulators of transcription.

Authors:  Sandeep Singh; Jackie Johnson; Srikumar Chellappan
Journal:  Biochim Biophys Acta       Date:  2010-07-15

5.  Genetic polymorphisms of p21 and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck.

Authors:  Dapeng Lei; Erich M Sturgis; Zhensheng Liu; Mark E Zafereo; Qingyi Wei; Guojun Li
Journal:  Carcinogenesis       Date:  2009-12-02       Impact factor: 4.944

6.  CDKN1A and CDKN1B polymorphisms and risk of advanced prostate carcinoma.

Authors:  Adam S Kibel; Brian K Suarez; Jay Belani; Joe Oh; Raul Webster; Michele Brophy-Ebbers; Chan Guo; William J Catalona; Joel Picus; Paul J Goodfellow
Journal:  Cancer Res       Date:  2003-05-01       Impact factor: 12.701

7.  Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer.

Authors:  Y J Li; P Laurent-Puig; R J Salmon; G Thomas; R Hamelin
Journal:  Oncogene       Date:  1995-02-02       Impact factor: 9.867

Review 8.  An emerging role for p21-activated kinases (Paks) in viral infections.

Authors:  Celine Van den Broeke; Maria Radu; Jonathan Chernoff; Herman W Favoreel
Journal:  Trends Cell Biol       Date:  2010-01-12       Impact factor: 20.808

Review 9.  p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review.

Authors:  Anita Koushik; Robert W Platt; Eduardo L Franco
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-01       Impact factor: 4.254

Review 10.  Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model.

Authors:  Ralph P Insinga; Erik J Dasbach; Elamin H Elbasha
Journal:  BMC Infect Dis       Date:  2009-07-29       Impact factor: 3.090

View more
  1 in total

1.  p27-V109G Polymorphism Is Not Associated with the Risk of Prostate Cancer: A Case-Control Study of Han Chinese Men in Central China.

Authors:  Meng Zhang; Qianjun Liang; Ligang Zhang; Zongyao Hao; Jun Zhou; Li Zhang; Song Fan; Chaozhao Liang
Journal:  Dis Markers       Date:  2018-03-20       Impact factor: 3.434

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.